Point72 Hong Kong’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$1.73K Buy
+224
New +$1.57K ﹤0.01% 429
2022
Q3
Sell
-12,261
Closed -$100K 2244
2022
Q2
$100K Buy
+12,261
New +$117K ﹤0.01% 1185
2021
Q3
Sell
-270
Closed -$12K 2297
2021
Q2
$12K Buy
+270
New +$12K ﹤0.01% 1716
2021
Q1
Sell
-846
Closed -$46K 2081
2020
Q4
$46K Buy
+846
New +$38.2K ﹤0.01% 1246
2019
Q4
Sell
-58
Closed -$1K 1355
2019
Q3
$1K Buy
+58
New +$1.36K ﹤0.01% 912
2019
Q2
Sell
-4,456
Closed -$91K 1307
2019
Q1
$91K Buy
4,456
+4,151
+1,361% +$72.1K 0.04% 397
2018
Q4
$4K Sell
305
-411
-57% -$6.13K ﹤0.01% 658
2018
Q3
$11K Buy
+716
New +$9.9K ﹤0.01% 655

Other funds holding NEO

Point72 Hong Kong's NEO Position: Q3 2025 in Review

Point72 Hong Kong opened a new position in NeoGenomics (NEO) in Q3 2025: 224 shares worth $1.73K. The stake represents ﹤0.01% of the portfolio and ranks #429 among its holdings. This is a return to the name: Point72 Hong Kong previously reported a position in NEO as recently as Q2 2022.

Point72 Hong Kong first reported a position in NEO in Q3 2018 and has held it in 8 quarters since. The position peaked at $100K in Q2 2022. 254 funds tracked by Wall St. Rank hold NEO as of Q3 2025.

  • Point72 Hong Kong held 224 shares of NeoGenomics worth $1.73K as of Q3 2025.
  • NeoGenomics was a new Point72 Hong Kong position in Q3 2025.
  • NeoGenomics made up ﹤0.01% of Point72 Hong Kong's portfolio in Q3 2025, its #429 holding.
  • Point72 Hong Kong first reported a position in NeoGenomics in Q3 2018 and has held it in 8 quarters since.
  • Point72 Hong Kong's NeoGenomics position peaked at $100K in Q2 2022.
  • 254 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2025.

Based on Point72 Hong Kong's 13F filing for Q3 2025, filed 14 Nov 2025.